The Trump administration announced on Tuesday that it will proceed with a $2.8 billion foreign‑military‑financing sale to Israel, delivering 40,000 2,000‑pound bombs – 20,000 Mk84 general‑purpose bombs and 20,000 BLU‑117 precision‑guided weapons. The deal, still pending final congressional review, reflects the administration’s commitment to a strong U.S.–Israeli alliance and to ensuring Israel has the tools it needs to protect its citizens.
Details of the proposed sale
Two U.S. officials and a source familiar with the plan confirmed that the package includes the 40,000 bombs, which are designed for a range of missions, from deep‑penetration strikes on underground targets to surface detonations intended to neutralize hostile infrastructure. Funding for the majority of the sale will come from foreign‑military‑financing, allowing U.S. taxpayer dollars to be transferred to Israel for the purchase.
Context and administration rationale
President Trump has repeatedly emphasized the strategic importance of a robust defense partnership with Israel. After the Biden administration paused the delivery of similar weapons in 2024, the Trump administration lifted that hold shortly after taking office, underscoring a clear policy shift toward unwavering support for Israel’s security needs.
In a recent statement, a senior administration official said the sale “strengthens Israel’s ability to defend itself against hostile actors and reinforces the long‑standing bond between our two nations.” The official added that the weapons are intended to deter aggression and protect innocent lives on both sides of the conflict.
Historical background
The United States has a long history of providing Israel with advanced munitions. Last year, the Trump administration approved a nearly $3 billion sale that included more than 35,500 bombs, and in January it authorized an additional $6.67 billion in arms sales. These actions demonstrate a consistent policy of ensuring Israel maintains a qualitative military edge in the region.
Reactions and criticism
Critics, including several human‑rights groups, have warned that the bombs could cause civilian casualties if used in densely populated areas. These groups are identified as advocacy organizations focused on Gaza humanitarian concerns. The administration, however, points to Israel’s stated intent to target legitimate military objectives, such as tunnel networks used by Hamas, and stresses that any use of force will be conducted in accordance with international law.
Impact on the broader Middle‑East strategy
The sale comes as the United States continues to navigate complex regional dynamics, including ongoing tensions with Iran. President Trump’s recent meeting with Prime Minister Benjamin Netanyahu reaffirmed the shared commitment to countering Iranian influence and protecting regional stability.
By moving forward with the bomb sale, the administration signals that policy disagreements – such as past friction over Iran – do not diminish the core strategic partnership. The decision also aligns with the administration’s broader foreign‑policy agenda of supporting allies that share democratic values and stand against extremist threats.
Looking ahead
Congress will review the proposed sale in the coming weeks. If approved, the weapons are expected to be delivered under existing foreign‑military‑financing arrangements, further cementing the United States’ role as Israel’s principal security partner.
Original reporting: Alexandria, VA News – WTOP News — read the source article.
